Enable job alerts via email!
Boost your interview chances
Create a job specific, tailored resume for higher success rate.
An established industry player is seeking a highly skilled professional to lead innovative research in digital and computational pathology. This role involves collaborating with cross-functional teams to enhance biomarker research and support oncology programs. The successful candidate will utilize their extensive experience in bioinformatics and computational biology to influence methodologies and drive clinical development decisions. Join a team that values scientific excellence and is dedicated to improving patient outcomes through cutting-edge research in oncology. If you are passionate about translating data into actionable insights, this opportunity is for you!
Join a Legacy of Innovation 125 Years and Counting!
Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 125 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 18,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.
Job Summary:
This role is part of Daiichi Sankyo Translational Science Oncology department and will participate in research towards utilizing digital and computational pathology approaches and related biomarker data for understanding drug mechanism of action, patient selection and patient enrichment strategies for programs across the clinical portfolio.
The successful candidate for this position will provide technical and scientific leadership in conducting histopathology and digital & computational pathology-based biomarker data analysis in support of translational science goals for oncology programs. The primary datasets will be derived mostly from analysis of Daiichi Sankyo sponsored clinical trials as well as pre-clinical data and may require bringing in additional sources of information.
S/he will contribute to the translational and precision medicine strategies by influencing methodologies, technologies and analysis utilized in translational research and deliver insights that will influence and drive clinical development decision-making. Besides global Bioinformatics teams, this role will require collaborating across functions and geographies with Translational Science Strategy leads, Clinical Pathology, Clinical Biomarkers and Biostats. Additionally, S/he will identify and interact with key external experts and collaborators and monitor progress toward goals of research programs.
Responsibilities:
Qualifications:
Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation.
Education:
Experience:
Competencies:
Travel: 0-10%
Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.